dc.contributor.author |
Ramia S. |
dc.contributor.author |
Sharara A.I. |
dc.contributor.author |
El-Zaatari M. |
dc.contributor.author |
Ramlawi F. |
dc.contributor.author |
Mahfoud Z. |
dc.contributor.editor |
|
dc.date |
Mar-2008 |
dc.date.accessioned |
2017-10-18T13:38:20Z |
dc.date.available |
2017-10-18T13:38:20Z |
dc.date.issued |
2008 |
dc.identifier |
10.1007/s10096-007-0429-7 |
dc.identifier.isbn |
|
dc.identifier.issn |
09349723 |
dc.identifier.uri |
http://hdl.handle.net/10938/20705 |
dc.description.abstract |
Occult hepatitis B virus (HBV) infection, characterised by the presence of HBV infection with undetectable hepatitis B surface antigen (HBsAg), was investigated in 98 Lebanese patients with chronic hepatitis C liver disease and 85 control subjects recruited from eight institutions in different parts of the country. The prevalence of occult HBV infection ranged from 11.9percent to 44.4percent in hepatitis C virus (HCV)-infected patients and it increased with increasing severity of the liver disease. The overall rate of HBV DNA in our 98 HCV-infected patients was 16.3percent. On the other hand, the rate of HBV DNA was 41.0percent in anti-HBc alone positive patients compared to only 7.1percent in healthy controls who were also anti-HBc alone positive (p 0.001). Moreover, the prevalence HBV DNA increased with increasing severity of the liver disease, but this increase was only marginally significant and, perhaps, could have been significant if more patients were involved in the study. Although Lebanon is an area of low endemicity for both HBV and HCV, occult HBV infection is common in HCV-infected patients. The presence of HBV DNA, therefore, presents a challenge for the effective laboratory diagnosis of hepatitis B, particularly if polymerase chain reaction (PCR)-based HBV detection methods are not used. © 2007 Springer-Verlag. |
dc.format.extent |
|
dc.format.extent |
Pages: (217-221) |
dc.language |
English |
dc.publisher |
NEW YORK |
dc.relation.ispartof |
Publication Name: European Journal of Clinical Microbiology and Infectious Diseases; Publication Year: 2008; Volume: 27; no. 3; Pages: (217-221); |
dc.relation.ispartofseries |
|
dc.relation.uri |
|
dc.source |
Scopus |
dc.subject.other |
|
dc.title |
Occult hepatitis B virus infection in Lebanese patients with chronic hepatitis C liver disease |
dc.type |
Article |
dc.contributor.affiliation |
Ramia, S., Department of Medical Laboratory Technology, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon |
dc.contributor.affiliation |
Sharara, A.I., Department of Internal Medicine, Faculty of Medicine, American University of Beirut, Beirut, Lebanon |
dc.contributor.affiliation |
El-Zaatari, M., Department of Medical Laboratory Technology, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon, Department of Laboratory Medicine, Hamoud Hospital, Saida, Lebanon |
dc.contributor.affiliation |
Ramlawi, F., Department of Medical Laboratory Technology, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon |
dc.contributor.affiliation |
Mahfoud, Z., Department of Epidemiology and Population Health, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon |
dc.contributor.authorAddress |
Ramia, S.; Department of Medical Laboratory Technology, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon; email: sramia@aub.edu.lb |
dc.contributor.authorCorporate |
University: American University of Beirut; Faculty: Faculty of Health Sciences; Department: Medical Laboratory Technology; |
dc.contributor.authorDepartment |
Medical Laboratory Technology |
dc.contributor.authorDivision |
|
dc.contributor.authorEmail |
sramia@aub.edu.lb |
dc.contributor.faculty |
Faculty of Health Sciences |
dc.contributor.authorInitials |
Ramia, S |
dc.contributor.authorInitials |
Sharara, AI |
dc.contributor.authorInitials |
El-Zaatari, M |
dc.contributor.authorInitials |
Ramlawi, F |
dc.contributor.authorInitials |
Mahfoud, Z |
dc.contributor.authorOrcidID |
|
dc.contributor.authorReprintAddress |
Ramia, S (reprint author), Amer Univ Beirut, Fac Hlth Sci, Dept Med Lab Technol, Beirut, Lebanon. |
dc.contributor.authorResearcherID |
|
dc.contributor.authorUniversity |
American University of Beirut |
dc.description.cited |
ALBERTI A, 1995, J HEPATOL, V22, P38; Allain JP, 2004, TRANSFUS CLIN BIOL, V11, P18, DOI 10.1016-j.tracli.2003.11.007; Cacciola I, 1999, NEW ENGL J MED, V341, P22, DOI 10.1056-NEJM199907013410104; Drosten C, 2004, J CLIN VIROL, V29, P59, DOI 10.1016-S1386-6532(03)00090-8; El-Zaatari M, 2007, J HOSP INFECT, V66, P278, DOI 10.1016-j.jhin.2007.04.010; Fukuda R, 1999, J MED VIROL, V58, P201, DOI 10.1002-(SICI)1096-9071(199907)58:3201::AID-JMV33.0.CO;2-2; Gilbert N, 2002, J VIROL METHODS, V100, P37, DOI 10.1016-S0166-0934(01)00396-2; Huo TI, 1998, HEPATOLOGY, V28, P231, DOI 10.1002-hep.510280130; Kao JH, 2000, INFEC DIS S, P313; Kao JH, 1997, GASTROENTEROLOGY, V112, P1265, DOI 10.1016-S0016-5085(97)70139-2; Koike K, 1998, J MED VIROL, V54, P249, DOI 10.1002-(SICI)1096-9071(199804)54:4249::AID-JMV33.0.CO;2-4; KOO JH, 2002, J CLIN MICROBIOL, V40, P4068; Lindh M, 1997, J INFECT DIS, V175, P1285; Michalak TI, 1999, HEPATOLOGY, V29, P928, DOI 10.1002-hep.510290329; Nabulsi Mona M, 2003, J Med Liban, V51, P64; Pollicino T, 2004, GASTROENTEROLOGY, V126, P102, DOI 10.1053-j.gastro.2003.10.048; Ramia S, 2005, EPIDEMIOL INFECT, V133, P695, DOI 10.1017-S0950268805003948; Rehermann B, 1996, NAT MED, V2, P1104, DOI 10.1038-nm1096-1104; SATO S, 1994, J HEPATOL, V21, P159, DOI 10.1016-S0168-8278(05)80389-7; Sharara AI, 2007, EPIDEMIOL INFECT, V135, P427, DOI 10.1017-S0950268806006911; Sharara AI, 2004, EUR J CLIN MICROBIOL, V23, P861, DOI 10.1007-s10096-004-1222-5; Torbenson M, 2002, LANCET INFECT DIS, V2, P479, DOI 10.1016-S1473-3099(02)00345-6; Uchida T, 1997, J MED VIROL, V52, P399, DOI 10.1002-(SICI)1096-9071(199708)52:4399::AID-JMV103.0.CO;2-C; Weber B, 2005, EXPERT REV MOL DIAGN, V5, P75, DOI 10.1586-14737159.5.1.75; Yotsuyanagi H, 2000, J INFECT DIS, V181, P1920, DOI 10.1086-315512; Zarski JP, 1998, J HEPATOL, V28, P27, DOI 10.1016-S0168-8278(98)80198-0; ZHANG YY, 1993, HEPATOLOGY, V17, P538, DOI 10.1002-hep.1840170403; Zignego AL, 1997, J MED VIROL, V51, P313 |
dc.description.citedCount |
9 |
dc.description.citedTotWOSCount |
7 |
dc.description.citedWOSCount |
6 |
dc.format.extentCount |
5 |
dc.identifier.articleNo |
|
dc.identifier.coden |
EJCDE |
dc.identifier.pubmedID |
18071765 |
dc.identifier.scopusID |
41049104194 |
dc.identifier.url |
|
dc.publisher.address |
233 SPRING STREET, NEW YORK, NY 10013 USA |
dc.relation.ispartofConference |
|
dc.relation.ispartofConferenceCode |
|
dc.relation.ispartofConferenceDate |
|
dc.relation.ispartofConferenceHosting |
|
dc.relation.ispartofConferenceLoc |
|
dc.relation.ispartofConferenceSponsor |
|
dc.relation.ispartofConferenceTitle |
|
dc.relation.ispartofFundingAgency |
|
dc.relation.ispartOfISOAbbr |
Eur. J. Clin. Microbiol. Infect. Dis. |
dc.relation.ispartOfIssue |
3 |
dc.relation.ispartOfPart |
|
dc.relation.ispartofPubTitle |
European Journal of Clinical Microbiology and Infectious Diseases |
dc.relation.ispartofPubTitleAbbr |
Eur. J. Clin. Microbiol. Infect. Dis. |
dc.relation.ispartOfSpecialIssue |
|
dc.relation.ispartOfSuppl |
|
dc.relation.ispartOfVolume |
27 |
dc.source.ID |
WOS:000253994000007 |
dc.type.publication |
Journal |
dc.subject.otherAuthKeyword |
|
dc.subject.otherChemCAS |
DNA, Viral |
dc.subject.otherChemCAS |
Hepatitis B Antibodies |
dc.subject.otherChemCAS |
Hepatitis B Surface Antigens |
dc.subject.otherIndex |
adult |
dc.subject.otherIndex |
article |
dc.subject.otherIndex |
chronic liver disease |
dc.subject.otherIndex |
controlled study |
dc.subject.otherIndex |
disease severity |
dc.subject.otherIndex |
female |
dc.subject.otherIndex |
genotype |
dc.subject.otherIndex |
hepatitis B |
dc.subject.otherIndex |
Hepatitis B virus |
dc.subject.otherIndex |
hepatitis C |
dc.subject.otherIndex |
Hepatitis C virus |
dc.subject.otherIndex |
human |
dc.subject.otherIndex |
Lebanon |
dc.subject.otherIndex |
major clinical study |
dc.subject.otherIndex |
male |
dc.subject.otherIndex |
prevalence |
dc.subject.otherIndex |
priority journal |
dc.subject.otherIndex |
prognosis |
dc.subject.otherIndex |
virus detection |
dc.subject.otherIndex |
Adult |
dc.subject.otherIndex |
DNA, Viral |
dc.subject.otherIndex |
Female |
dc.subject.otherIndex |
Hepatitis B |
dc.subject.otherIndex |
Hepatitis B Antibodies |
dc.subject.otherIndex |
Hepatitis B Surface Antigens |
dc.subject.otherIndex |
Hepatitis B virus |
dc.subject.otherIndex |
Hepatitis C, Chronic |
dc.subject.otherIndex |
Humans |
dc.subject.otherIndex |
Lebanon |
dc.subject.otherIndex |
Male |
dc.subject.otherIndex |
Middle Aged |
dc.subject.otherIndex |
Prevalence |
dc.subject.otherIndex |
Viral Load |
dc.subject.otherKeywordPlus |
ACUTE VIRAL-HEPATITIS |
dc.subject.otherKeywordPlus |
HBV INFECTION |
dc.subject.otherKeywordPlus |
BLOOD-DONORS |
dc.subject.otherKeywordPlus |
DNA |
dc.subject.otherKeywordPlus |
COINFECTION |
dc.subject.otherKeywordPlus |
SERUM |
dc.subject.otherKeywordPlus |
PREVALENCE |
dc.subject.otherKeywordPlus |
ANTIBODIES |
dc.subject.otherKeywordPlus |
GENOTYPES |
dc.subject.otherKeywordPlus |
ANTIGEN |
dc.subject.otherWOS |
Infectious Diseases |
dc.subject.otherWOS |
Microbiology |